102 related articles for article (PubMed ID: 17448595)
1. Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomy.
Lin DW
Eur Urol; 2008 Feb; 53(2):345-6. PubMed ID: 17448595
[No Abstract] [Full Text] [Related]
2. Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomy.
van der Poel HG
Eur Urol; 2008 Feb; 53(2):344. PubMed ID: 17448596
[No Abstract] [Full Text] [Related]
3. Marked gene transcript level alterations occur early during radical prostatectomy.
Schlomm T; Näkel E; Lübke A; Buness A; Chun FK; Steuber T; Graefen M; Simon R; Sauter G; Poustka A; Huland H; Erbersdobler A; Sültmann H; Hellwinkel OJ
Eur Urol; 2008 Feb; 53(2):333-44. PubMed ID: 17448597
[TBL] [Abstract][Full Text] [Related]
4. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis.
Lin DW; Coleman IM; Hawley S; Huang CY; Dumpit R; Gifford D; Kezele P; Hung H; Knudsen BS; Kristal AR; Nelson PS
J Clin Oncol; 2006 Aug; 24(23):3763-70. PubMed ID: 16822846
[TBL] [Abstract][Full Text] [Related]
5. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
6. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
van der Poel HG
Eur Urol; 2009 May; 55(5):1133-4. PubMed ID: 18585847
[No Abstract] [Full Text] [Related]
7. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Berney DM
Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844
[No Abstract] [Full Text] [Related]
8. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
9. Application of gene microarrays in the study of prostate cancer.
Nelson CC; Hoffart D; Gleave ME; Rennie PS
Methods Mol Med; 2003; 81():299-320. PubMed ID: 12725128
[No Abstract] [Full Text] [Related]
10. Differential gene expression in the peripheral zone compared to the transition zone of the human prostate gland.
Noel EE; Ragavan N; Walsh MJ; James SY; Matanhelia SS; Nicholson CM; Lu YJ; Martin FL
Prostate Cancer Prostatic Dis; 2008; 11(2):173-80. PubMed ID: 17646851
[TBL] [Abstract][Full Text] [Related]
11. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Fritzsche FR; Jung M; Tölle A; Wild P; Hartmann A; Wassermann K; Rabien A; Lein M; Dietel M; Pilarsky C; Calvano D; Grützmann R; Jung K; Kristiansen G
Eur Urol; 2008 Nov; 54(5):1097-106. PubMed ID: 18061337
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF
Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Bastian PJ
Eur Urol; 2009 Feb; 55(2):420. PubMed ID: 19027222
[No Abstract] [Full Text] [Related]
14. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Cooper C
Eur Urol; 2008 Nov; 54(5):1107-8. PubMed ID: 18061340
[No Abstract] [Full Text] [Related]
15. Editorial comment on: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Valentini A; Bernardini S
Eur Urol; 2008 Nov; 54(5):1106-7. PubMed ID: 18061338
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Türkeri L
Eur Urol; 2008 Mar; 53(3):562-3. PubMed ID: 17683853
[No Abstract] [Full Text] [Related]
17. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Hara N
Eur Urol; 2008 Sep; 54(3):598-9. PubMed ID: 18226440
[No Abstract] [Full Text] [Related]
18. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Fütterer JJ; Barentsz JO
Eur Urol; 2008 Sep; 54(3):599-600. PubMed ID: 18226439
[No Abstract] [Full Text] [Related]
19. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
van der Poel HG
Eur Urol; 2008 Mar; 53(3):561-2. PubMed ID: 17683855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
